Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novelion Therapeutics Inc (NASDAQ:NVLN)

9.25
Delayed Data
As of Jan 18
 +0.15 / +1.65%
Today’s Change
6.10
Today|||52-Week Range
13.80
+9.86%
Year-to-Date
5 Expensive Drugs That Could End Up in Trump's Crosshairs
Jan 18 / MotleyFool.com - Paid Partner Content